Download View CV - Rutgers New Jersey Medical School

CURRICULUM VITAE
DATE:
May 10, 2016
NAME:
Glenn J. Fennelly, MD, MPH
PRESENT TITLE:
Chair, Department of Pediatrics, Rutgers New Jersey Medical School
OFFICE ADDRESS:
Department of Pediatrics, MSB-F540, 185 S. Orange Ave, Newark, NJ 07103
CITIZENSHIP:
USA
EDUCATION:
Undergraduate
Dartmouth College
Hanover, NH
BA (English/Biology)
May 1982
Graduate and Professional
UMDNJ-New Jersey Medical School
Newark, NJ
MD (Medicine)
June 1987
Harvard School of Public Health
Boston, MA
MPH (Clinical Effectiveness)
POSTGRADUATE TRAINING:
Internship and Residencies
Montefiore Medical Center, Bronx, NY
Pediatrics
Montefiore Medical Center, Bronx, NY
General Academic Pediatrics
December 2005
July 1987-June 1990
July 1990-1991
Subspecialty Fellowship
Montefiore Medical Center-Albert Einstein College of Medicine
Pediatric Infectious Diseases
July 1991-June 1995
MILITARY: not applicable
ACADEMIC APPOINTMENTS:
Department of Pediatrics
Rutgers New Jersey Medical School
Chair
October 2013-present
Department of Pediatrics
Rutgers New Jersey Medical School
Professor of Pediatrics
January 2014-present
Department of Pediatrics
Albert Einstein College of Medicine (Einstein)
Professor of Clinical Pediatrics
November 2011-Dec 2013
Department of Pediatrics
Albert Einstein College of Medicine
Page 1 of 14
Associate Professor of Clinical Pediatrics
June 2003-Nov 2011
Department of Pediatrics
Albert Einstein College of Medicine
Assistant Professor of Pediatrics
July 1995-June 2003
HOSPITAL APPOINTMENTS:
Lewis M. Fraad Department of Pediatrics
Jacobi Medical Center
Chief, Division of Pediatric Infectious Diseases
Department of Pediatrics
Montefiore Medical Center
Attending Pediatrician
June 1998-October 2013
July 1994-June 1998
OTHER EMPLOYMENT OR MAJOR VISITING APPOINTMENTS: not applicable
PRIVATE PRACTICE: not applicable
LICENSURE:
Physician, New Jersey State (Lic. #25MA09384900)
Physician, New York State (Lic. #177223)
Expir. 6/16
Expir. 2/17
DRUG LICENSURE:
DEA
#BF7818264
NJ CDS #D10305900
Expir. 9/16
Expir. 10/16
CERTIFICATION:
Diplomat, Pediatric Infectious Diseases
Diplomat, American Board of Pediatrics
Expir. 2018
Expir. 2024
MEMBERSHIPS, OFFICES AND COMMITTEE ASSIGNMENTS IN PROFESSIONAL
SOCIETIES:
Member
Association of Medical School Pediatric Department Chairs 2013-present
New York Society for Infectious Diseases
2002-05
Infectious Diseases Society of America/HIVMA
2002-05
Pediatric Infectious Diseases Society of America
1995-01
American Society for Microbiology
1998-01
HONORS AND AWARDS:
Young Investigator Award
National Foundation for Infectious Diseases
1997
The Leo M. Davidoff Society Certificate of Distinction
Albert Einstein College of Medicine
1991
Connaught Laboratories Pediatric Infectious Disease
Fellowship Award Infectious Diseases Society of America
BOARDS OF DIRECTORS/TRUSTEES POSITIONS:
Member, Board of Directors, Doctors of the World
Chair, Program Committee, Doctors of the World
1991
1997-1998
1997-1998
SERVICE ON NATIONAL GRANT REVIEW PANELS, STUDY SECTIONS, COMMITTEES:
Page 2 of 14
National Institutes of Health
NIAID ZRG1 AARR-M 57 Mycobacterial Induced Immunity in
HIV-Infected and Uninfected Individuals (2016)
National Center for Research Resources Special Emphasis Panel
ZRR1 CM-6 (2012)
NIAID Innovations in HIV Vaccines ZAI1-DR-A-M1 (2003-12)
Chair, NIH Special Panel for AIDS Pre- and Postdoctoral
Fellowships (2010-11)
NIAID International Research in Infectious Diseases/AIDS (2010)
NIAID Special Emphasis Panel ZRG1 (2009)
NIAID Innovation in AIDS Research and Human Immunology
(2002-07)
NBIB “Gene and Drug Delivery” (2004)
NIAID Special Emphasis Panel for HIV-Vaccines, Immunology &
Molecular Biology, Hepatitis, and Bioterrorism (2002)
March of Dimes
Biomedical Research Funding Peer Review Panel
SERVICE ON MAJOR COMMITTEES:
International
Vietnamese National Health Pediatric HIV and Opportunistic
Infection Treatment Guidelines Writing Group
National
Emerging Infections Network, IDSA
NYC HHC Pediatric HIV Special Needs Working Group,
AIDS Institute, NY
Rutgers Biomedical and Health Sciences, Rutgers University
Rutgers Health Care Transformation/Clinical Operations Working
Committee
Member, Autism Research Center Search Committee
Advisory Panel on Potential Student 4CMenB Immunization
Chair, Search Committee for Chair of Department of OB/GYN
Albert Einstein College of Medicine
Professors Promotion Committee
Global Health Center Pilot Grants Panel
CFAR Development Core Grants Panel
Global Health Center Planning Committee
Hospital
Infection Control Committee, Jacobi Hospital
Department
Infectious Prevention Committee, Pediatrics, Jacobi
Editorial Boards
Infectious Disease Emergencies, in Crain EF, Gershel, JC (eds.):
Clinical Manual of Emergency Pediatrics McGraw-Hill
AdHoc Reviewer
Vaccine
Immunology Letters
FEMS Immunology & Medical Microbiology
Clinical Infectious Diseases
Journal of Infectious Diseases
SERVICE ON HOSPITAL COMMITTEES:
Executive Subcommittee of the Medical Executive Committee,
University Hospital, Newark
Page 3 of 14
2006
2008
2001-present
1998-1999
20162016
2014
2014
2013
2008
2005
2005
1998-2013
1998-2013
2010
20102007200619951995-
2013-
Medical Executive Committee,
Pediatric Research Committee, Montefiore
Infection Control Committee, Jacobi Hospital
SERVICE TO THE COMMUNITY:
National:
Board of Directors, Manhattan Youth
International:
Consultant and Mentor, Pediatric HIV Care
Vietnam-CDC-Harvard AIDS Partnership
Volunteer Mentor, Global Medic Force, Vietnam
Volunteer, Doctors of the World-USA
Emergency medical relief, Chiapas
TB DOT implementation, Kosovo
Mass immunization, clinical care, Kosovo
1994-1998
1998-2013
1997-98
2006-08
2006
1994
1994
1992
SPONSORSHIP (Primary Mentorship) OF POSTDOCTORAL FELLOWS:
Name/Dates
Uma Ranganathan, PhD
2003-2013
Mayami Sengupta, PhD
2009-2011
Lydia Tesfa, PhD
2004-2008
Yongkai Mo, MD, PhD
2004-2006
William Vecino, MD
1998-2005
Jyothi Kondapalli, PhD
1998-1999
Project
Novel combination Pediatric HIV-TB
vaccine development
Current Position
Chief, Bacteriology Department,
National Institute for
Tuberculosis, Chennai, India
Mucosal immunization with a
Postdoctoral Associate
combination Pediatric HIV-TB vaccine
Department of Biotechnology
University of Florida,
Gainesville
T cell responses to novel mycobacteria- Research Assistant Professor,
based HIV and HPV vaccines
Micro & Immunology
Einstein
Novel “myco-bactofection” immunization Postdoctoral Fellow,
technique
Developmental & Molecular
Biology Department,
Einstein
Mucosal vaccines against HIV and
VP, Medical Director
influenza
Saatchi & Saatchi
Mucosal DNA vaccination
Research Assist Professor of
Physiology, Northwestern Univ.
TEACHING RESPONSIBILITIES:
A. Lectures or Course Directorships
Undergraduate Medical Education
Summer Medical and Dental Education Program (Rutgers-NJMS)
2015-present
HIV. From Ignorance to Intelligence: a 30-year perspective of a
pediatric & adolescent infectious diseases physician
Rutgers-NJMS
Problem-Based Learning: Fever in Baby, Vaccination
2013-present
Einstein
Jacobi Pediatric Infectious Diseases 4th-Year Student Elective
Jacobi 3rd-Year Student General Pediatrics Clerkship
1999-2013
1998-2013
Page 4 of 14
Graduate Medical Education
Rutgers-New Jersey Medical School
Morning Report Leader
2013-present
Einstein
National Institute for Reproductive Health adolescent interview
2010
Lecturer, Global Health Course, Montefiore Social Pediatrics,
Barriers to Vaccination against New and Emerging Infectious 2006-2010
Threats
Grand Rounds Lewis M. Fraad Department of Pediatrics, Jacobi
Update on Candidate HIV and TB Vaccines
2007
Global ART Scale Up to Prevent and Treat Pediatric HIV
2006
Pediatric travel-related illnesses in the acute care setting
2006
A Child with Fever and Pancytopenia
2005
Dengue Fever
2005
Infectious Diseases Rotation, Jacobi Pediatrics Residency
1998-2013
Morning Report Facilitator, Jacobi Pediatrics Residency
1998-2013
Infectious Diseases Fellowship Training Program-Einstein
1998-2013
Resident Core Lecture Series, Jacobi Pediatrics
1998-2013
Pediatric Antibiotic Therapy in an Era of Emerging Resistance
Diagnosis and Management of Osteomyelitis
Diagnosis and Management of TB in Children
Clinical Microbiology mini-rotation, Jacobi Microbiology Laboratory 1998-2013
Graduate School Teaching
Mentor, Einstein Microbiology & Immunology MD-PhD candidates
1998-2009
Continuing Medical Education
Workshop Leader Einstein Pediatric Alumni Day: Current Antibiotic
Selection for Common Infections
2010
Jacobi-New York City Department of Health, City-Wide TB Rounds 1995-2010
Invited Speaker, Einstein Pediatric Alumni Day: Progress towards a
Pediatric Combination TB/HIV Vaccine for Africa
2008
Einstein Global Health Seminar HIV Therapy Scale Up in Vietnam
2008
Einstein Obstetrics and Gynecology Department Global Health Seminar
Tuberculosis: Current Global Perspectives
2006
Einstein Cancer Center Working Group, Regulatory T cells in HPV
-associated Cervical Cancer
2005
Einstein Infectious Diseases Subspecialty Board Review and Update
Einstein CFAR Seminar, Novel T cell immunogens against HIV
2004
Einstein Infectious Diseases Subspecialty Board Review and Update
Course
Non-tuberculous Mycobacteria
2001-2005
Upper Respiratory Tract Infections
2001
B. Research Training:
External and Visiting Postdoctoral Research Fellows
Name/Dates
Project
Susan Bueno, PhD 2005Novel BCG-RSV vaccine development
2006
Paul Morin, PhD 1999-2000 HIV vaccines/Mucosal immunology
Rabia Agha, MD 1994-1997 Shigella-DNA vaccination
Page 5 of 14
Current Position
Assistant Professor, Biology,
Catholic University, Chile
Investigator, US Food and Drug
Administration, Queens, NY
Chief, Pediatric Infectious
Diseases Division, Beth Israel
Medical Center, NY, NY
Einstein Medical-Scientist Training Program Student Adviser/Mentor
Name/Dates
Project
Current Position
Natalie Quanquin, MD, PhD Ad hoc PhD thesis adviser;
Fellow, Pediatric Infectious
2003-2008
Novel mycobactofection method
Diseases UCLA
Robert Glover, PhD 1999- Member, PhD thesis committee;
Healthcare Consultancy Group,
2005
Recombinant BCG vaccines against
San Francisco, CA
cancer
CLINICAL RESPONSIBILITIES:
Chief of Service, University Hospital, Newark, NJ: I supervise approximately 50 Pediatric
attending physicians and PhD clinicians that are Rutgers Faculty including general pediatric
hospitalists, intensivists, emergency medicine pediatricians, neonatologists, and several other
subspecialists including infectious diseases, allergy, immunology endocrinology, cardiology,
genetics, gastroenterology and pulmonology; oversee departmental quality insurance
2013-present
Division Director, Einstein-Jacobi Hospital Pediatrics: I supervised and coordinated clinical
consultation, patient care, educational and research activities of four ABP-Certified Infectious
Diseases physicians and two nurse practitioners, and advised on best practices in the use of
pediatric vaccines and antimicrobials.
1998-2013
Provider, Jacobi Pediatric HIV Treatment Services Clinic: I coordinated a team providing care
to a large cohort (> 200) of children with HIV
1996-2013
Member, Jacobi Infection Prevention Committee: I advised an interdisciplinary team of
physicians, nurses, microbiologists and pharmacists on issues particular to infection control in
children, and contributed to clinical practice guidelines.
1998-2013
Hospital Attending, Jacobi Pediatrics: I taught the management of common pediatric problems
to Einstein MSIIIs and MSIV students using problem-based learning, teaching rounds and case
discussions
1998-2013
GRANT SUPPORT: (NIH grants and type of NIH grants are in bold)
A. Glenn Fennelly, PI
Current
1. Rutgers NJMS Dean’s Support 7/1/06-6/30/09
2. Merck Gardasil 9 Effectiveness in Discordant Couples, co-investigator (Mark
Einstein, PI)
7/1/06Past
1. NIH/NIAID/NIDCR, R01 Supplement to extend DE019064-06, Glenn Fennelly
(Rutgers), Michelle Larsen (Einstein) and Kristina Abel (UNC) co-PIs Oral
Attenuated Mycobacterial Vaccines against Breast Milk HIV Transmission
6/1/14-8/15/15
2. NIH/NIDCR, R01 DE019064, Multi-PI R01, Glenn Fennelly (Rutgers), Michelle
Larsen (Einstein) and Kristina Abel (UNC) Oral Attenuated Mycobacterial Vaccines
against Breast Milk HIV
6/1/08-5/31/15
3. NIH/NIAID, R03 AI097040, Indo-US Vaccine Action Plan: Attenuated HIV/TB
Vaccine for India,
8/17/11-8/16/14 (NCE)
4. NIBIB/NCI, R21 EB002857, Nonpathogenic Mycobacteria for Anti-Bladder Tumor
Gene Therapy,
7/01/04-6/30/06
5. Einstein CFAR Pilot Project, “CD8+ T cells Against Human Papillomavirus in
Woman with HIV Infection.” 5/1/02-4/30/03
Page 6 of 14
Elizabeth Glaser Pediatric AIDS Foundation Basic Research Award. “Mucosal DNA
Vaccines against Oral SIV in Newborn Rhesus Monkeys”.
4/1/99-3/30/03
7. NIAID, R21 “Mucosal DNA Vaccines for T Cells Against HIV”
9/30/98-9/29/02
8. Department of Pediatrics, Einstein, Internal Grant Award, “Shigella Delivery
Vehicles for DNA Vaccines against Measles”.
7/1/97-6/30/98
9. National Foundation for Infectious Diseases Young Investigator Award, “Shigella
Vectors for DNA Vaccines against Measles.”
4/30/97-4/29/98
10. NIAID K11, Physician Scientist Award. “Recombinant BCG Priming for T cells
Against Measles”.
7/1/94-6/30/99
11. Connaught Laboratories Pediatric Infectious Diseases Fellowship Award (Fennelly,
PI) “A study of measles antibody levels in infants born to women that acquired
measles immunity from immunization.”
9/1/91-8/30/92
6.
B. Co-Investigator
12. NIH/NIAID P01 AI52816-01A1 (Barton Haynes, PI) (Subcontract from Duke
Univ.) “HIV, TB and Malaria Vaccine Development for Africa. Project 3 “HIV CTL
Immunogens for Expression in Attenuated Mycobacteria”. Co-Principal Investigator
on Project 3
8/15/03-8/14/08
13. NIAID, PACTG (Andrew Wiznia, PI), Jacobi Medical Center. Co-Investigator
6/1/98-6/30/12
14. NIH/NIAID R01 AI060379-01 (Nixon, PI), (Subcontract for UCSF to Jacobi
Medical Center). “Cell Mediated Immunity in HIV-Infected Children”. Coinvestigator.
7/1/04-6/30/09
15. NIH/NIAID R01 AI060379-01 (Nixon, PI), (Subcontract for UCSF to Jacobi).
Elizabeth Glaser Pediatric AIDS Foundation. (Nixon, PI) “A Study of Cellular
Immune Responses in HIV-1 Infected (Pregnant) Women and their HIV-1 Exposed
Offspring”. Co-investigator
3/1/01-2/27/03
C. Pending: none
PUBLICATIONS:
A.
Refereed Original Articles
1. Fennelly GJ, Flynn JL, ter Muelen V, Liebert UG, Bloom BR; Recombinant bacille
Calmette Guerin priming against measles. Journal of Infectious Diseases. 172:698705, 1995.
2. Zhu, YD, Fennelly GJ, Miller C, Tarrara R, Saxe I, Bloom BR, McChesney M.
Recombinant bacille Calmette Guerin expressing the measles nucleoprotein protects
infant rhesus macaques from measles pneumonia. Journal of Infectious Diseases.
176:1445-53, 1997.
3. Fennelly GJ, Khan SA, Abadi M, Wild FB, Bloom BR. Mucosal DNA vaccine
immunization against measles with a highly attenuated Shigella flexneri vector.
Journal of Immunology. 162:1603-1610, 1999.
4. Spiegel HML, Chandwani R, Megam ES, Dobroszycki J, Fennelly G, Wiznia A,
Rading J, Rigaud M, Pollack M, Borkowsky W, Rosenberg M, Nixon DF. The
impact of early highly active antiretroviral drug treatment on the HIV-specific
cytotoxic T cell response in HIV-1 infected children. Journal of Infectious Diseases.
182(1):88-95, 2000.
5. Hogan HL, Macvilay K, Barger B, Co D, Malkovska I, Fennelly G, Sandor M.
Mycobacterium bovis strain BCG-induced liver granulomas contain a diverse TCR
Page 7 of 14
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
repertoire, but a monoclonal T cell population is sufficient for protective granuloma
formation. Journal of Immunology. 166(10):6367-75 2001.
Vecino WH, Morin P, Jacobs WR, Fennelly GJ. Mucosal DNA Vaccination with
Highly Attenuated Shigella is Superior to Attenuated Salmonella and Comparable to
Intramuscular DNA Vaccination for T cells Against HIV. Immunology Letters. 82(2)
197-204, 2002.
Sandberg JK, Fast NM, Palacios EH, Fennelly G, Dobroszycki J, Palumbo P,
Wiznia A, Grant RM, Bhardwaj N, Rosenberg MG, Nixon DF. Selective loss of
innate CD4 (+) V alpha 24 natural killer T cells in human immunodeficiency virus
infection. Journal of Virology. 76(15):7528-34, 2002
Sandberg JK, Fast NM, Jordan KA, Furlan SN, Barbour JD, Fennelly G,
Dobroszycki J, Spiegel HM,Wiznia A, Rosenberg MG, Nixon DF. HIV-specific
CD8+ T cell function in children with vertically acquired HIV-1 infection is
critically influenced by age and the state of the CD4+ T cell compartment. Journal of
Immunology. 170(8):4403-10, 2003
Vecino WH, Quanquin NM, Martinez-Sobrido L, Fernandez-Sesma A, García-Sastre
A, Jacobs, W R, Jr., and Fennelly GJ. Mucosal immunization with attenuated
Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice
against a lethal influenza challenge. Virology. 325(2):192-9, 2004.
Legrand FA, Abadi J, Jordan KA, Davenport MP, Deeks SG, Fennelly GJ, Wiznia
AA, Nixon DF, and Rosenberg MG. Partial treatment interruption of protease
inhibitors augments HIV-specific immune responses in vertically infected pediatric
patients. AIDS. 19(15):1575-1585, 2005.
Cayabyab MJ, Hovav AV, Hsu T, Krivulka GR, Lifton NA, Gorgone DA, Fennelly
GJ, Haynes BF, Jacobs, WR Jr. and Letvin NL. Generation of CD8+ T cell
Responses by a Recombinant Nonpathogenic Mycobacterium smegmatis Vaccine
Vector Expressing HIV-1 Env. Journal of Virology 80(4):1645-1652, 2006.
Abadi J, Sprecher E, Rosenberg MG, Dobroszycki J, Sansary J, Fennelly G and
Wiznia A. Partial Treatment Interruption of PI-Based HAART Regimens in HIVInfected Children. Journal of Acquired Immune Deficiency Syndromes. 41(3):298303, 2006.
Raffaelli RM, Paladini M, Hanson H, Kornstein L, Agasan A, Slavinski S, Weiss W,
Fennelly GJ, Flynn JT. M.S. E.coli O157:H7 Diarrhea and Hemolytic-Uremic
Syndrome in an Urban Daycare Child Care Center. Pediatric Infectious Diseases
Journal. 26(10):951-953, 2007.
Ballan WM, N. Vu BA, Long BR, Loo CP, Michaëlsson J, Barbour JD, Lanier LL,
Wiznia AA, Abadi JB, Fennelly GJ, Rosenberg MG, Nixon DF. Natural Killer Cell
Changes in Perinatally HIV-1 Infected Children. Journal of Immunology. 179(5):
3362-70, 2007.
Mo Y, Quanquin NM, Vecino WH, Devi Ranganathan U, Tesfa L, Derbyshire, KM,
Letvin NL, Jacobs, WR Jr, Fennelly GJ. Genetic Alteration of Mycobacterium
smegmatis to Improve Mycobacterial Bactofection and DNA Immunization.
Infection and Immunity. 75(10):4804-16, 2007.
Bueno SM, González PA, Cautivo KM, Mora JE, Leiva ED, Tobar HE, Fennelly
GJ, Eugenin EA, Jacobs WR Jr, Riedel CA, Kalergis AM. Protective T cell
immunity against respiratory syncytial virus is efficiently induced by recombinant
BCG. Proceedings of the National Academy of Sciences U S A. 105(52):20822-7.
2008.
Ranganathan UD, Larsen MH, Kim J, Porcelli SA, William Jacobs WR Jr, Fennelly
GJ. Recombinant Avirulent Proapoptotic M. tuberculosis Generates CD8+ T-cell
Responses against Human Immunodeficiency Virus Type 1 Env in Neonatal Mice.
Vaccine. 28(1):152-6, 2009.
Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia
AA, Rosenberg MG, Nixon DF. Immunodominance of HIV-1 Specific CD8+ T-Cell
Responses Is Related to Disease Progression Rate in Vertically Infected Adolescents.
PLoS One. 6(7):e21135, 2011
Page 8 of 14
19. Sharp ER, Willberg CB, Kuebler PJ, Abadi J, Fennelly GJ, Dobroszycki J, Wiznia
AA, Rosenberg MG, Nixon DF. Association of Differentiation State of CD4+ T
Cells and Disease Progression in HIV-1 Perinatally Infected Children. PLoS One.
7(1):e29154, 2012.
20. Jensen K, Ranganathan UD, Van Rompay K, Canfield DR, Khan I, Ravindran R,
Luciw PA, Jacobs WR Jr, Fennelly G, Larsen M, Abel K. A recombinant attenuated
Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed SIVinfected infant macaques. Clinical Vaccine Immunology. 19(8):1170-81, 2012
21. Jensen K, de la Pena M, Wilson R, Ranganathan UD, Jacobs W, Jr, Fennelly G,
Larsen M, Van Rompay K, Kozlowski P, and Abel K. A neonatal oral
Mycobacterium tuberculosis-SIV prime/intramuscular MVA-SIV boost combination
vaccine induces both SIV and M. tuberculosis-specific immune responses in infant
macaques. Trials in Vaccinology 2:53-63,2013
22. Tartof SY, Gounder P, Weiss D, Lee L, Cassiday PK, Clark TA, Briere EC, Whittier
S, Fennelly G, Zhao B, del Rosso P, Dorsinville MS, L. Tondella ML, Woods-Stout
D, Shannon MW, Cierzniewski A, Baumbach J, Kathy Kudish K, Maxted A.
Bordetella holmesii Bacteremia Cases in the United States, April 2010–January
2011. Clinical Infectious Diseases 58 (2): e39-e43, 2014
B.
Books, Monographs and Chapters
1. Fennelly GJ, Jacobs WR Jr, Bloom BR. Recombinant BCG as a vaccine vehicle. In:
New Generation Vaccines; Woodrow GC, Levine MM, eds. 363-78, Marcel Dekker,
New York, 1997.
2. Rosenberg M and Fennelly GJ: Infectious Disease Emergenices, in Clinical Manual
of Emergency Pediatrics (5th ed), Crain EF, Gershel, JC (eds.), McGraw-Hill, New
York, 2010
C.
Patents Held
1. “Attenuated Mycobacteria as Vectors for Gene Delivery to Mammalian Cells”, U.S.
20080268541, 10-30-2008, William R. Jacobs, Jr. and Glenn J. Fennelly
D.
Other Articles (Reviews, Editorials, etc.) In Journals; Chapters; Books; other Professional
Communications
1. Fennelly GJ. Listeria monocytogenes. Pediatrics in Review. 13(7):277, 1992.
2. Fennelly GJ. Rifampin prophylaxis. Pediatrics in Review. 13(9):354, 1992.
3. Fennelly GJ. Prevention of Neisseria meningitidis. Pediatrics in Review.
13(10):370. 1992.
4. Fennelly GJ. Measles vaccine. Pediatrics in Review. 1998 May; 19(5):178-9.
5. Fennelly GJ. Pasteurella infections. Pediatrics in Review. 13(10):394, 1992.
6. Shah F, Fennelly G, Weingarten-Arams J, Yang L, Glickstein J. Endocardial
abscesses in children: Case report and review of the literature. Clinical Infectious
Diseases. 29:1478-82, 1999.
7. Eaton EE, Dobroszycki J, Loas R, Laddis D, Fennelly GJ. Non-typhoidal
Salmonella Bacteremia and Pneumonia as the Initial Manifestation of HIV Infection
in a 4-Year-Old Child. AIDS Patient Care and STDs. 16(6):247-50, 2002
8. Fennelly GJ. Mycobacterium bovis versus Mycobacterium tuberculosis as a cause
of acute cervical lymphadenitis without pulmonary disease. Pediatric Infectious
Diseases Journal. 23(6):590-1, 2004.
9. Fennelly GJ. Therapy for Mycobacterium bovis. Pediatric Infectious Diseases
Journal. 23(11):1072, 2004.
10. Fennelly GJ. And Charles M, Opportunities to prevent mother-to-child transmission
(PMTCT) of HIV: Lessons learned in Bronx (New York), Kijabe (Kenya) and
Kericho (Kenya). PART I of II. Perspectives from the International Center for Equal
Healthcare Access. Medscape. 2006.
Page 9 of 14
11. Egland E.G., Egland T.K. and Fennelly G. Pyelonephritis. In: Steele R, ed.
eMedicine Online Textbook of Pediatric Infectious Diseases, www.emedicine.com
3: 2, 2010
12. Larsen MH, Jacobs WR, Porcelli SA, Kim J, Ranganathan UD, Fennelly GJ.
Balancing safety and immunogenicity in live-attenuated mycobacterial vaccines for
use in humans at risk for HIV. Vaccine. 28(21):3633-4, 2010.
13. Chen SS, Fennelly G. Measles. Medscape Reference. Available at:
http://emedicine.medscape.com/article/966220-overview. Updated July 22, 2013.
14. Jani N, Thomas P, Harris D, Halperin W, Fennelly G. Impact of Religion-Based
Childhood Vaccine Exemption Practice among Kindergarteners in New Jersey by
State Legislative District in 2013-14. New Jersey Pediatrics. 12-15, Summer 2015.
15. Liu G, Fennelly G, Kazacos K, Grose C, Dobroszycki, Joanna, Saffra, Norman,
Coyle, Christine, Weiss, Louis, Szlechter, Moshe, Tanowitz, Herbert. Baylisascaris
procyonis and Herpes simplex Virus 2 co-infection Presenting as Ocular Larva
Migrans with Granuloma Formation in a Child Running. American Journal of
Tropical Medicine & Hygiene. 2015 Jun 29. pii: 15-0272.
E.
Abstracts (selected)
1. Billeter MA, Bellini W, Van Binnendijk RS, Borrow P, Brown F, Cutts F, Fennelly
G et al. The pathogenetic aspects of measles virus infection: Memorandum from a
WHO Meeting on the Pathogenetic Aspects of Measles Virus Infection. Bulletin of
the WHO. 72:199-206, 1994
2. Fennelly GJ, Fox AS, Quijano E, Bashir M, Spigland I. Increased susceptibility to
measles in infants born to young mothers in New York City. Program and Abstracts
of the 33rd annual Interscience Conference on Antimicrobial Agents and
Chemotherapy, 1993.
3. Fennelly GJ, Zhu YD, Bloom BR, McChesney MM. Recombinant bacille Calmette
Guerin (rBCG) administered to newborn rhesus monkeys engenders partially
protective immune responses against measles. European Research Conference on the
Immunology of Infections. Giens, France October 11-16, 1996.
4. Morin P, Kondapalli J, Fennelly GJ. Mucosal DNA Vaccines against HIV.
National Institutes of Health Workshop on HIV Vaccines Development, Bethesda,
MD. May 5-6, 1999.
5. Rosenberg M, Dobroszycki J, Fennelly G, Sansary J, Burton-Goode J, Wiznia A.
Long-term follow-up of HIV-1 infected children initiating HAART early in infancy.
7th Annual Conference on Retroviruses and Opportunistic Infections, San Francisco,
CA. Jan. 29-Feb. 2, 2000.
6. Fast NM, Sandberg JK, Rosenberg, M, Spiegel HML, Fennelly G, Dobroszycki J,
Wiznia A, Nixon DF. Natural Killer T Cell Subsets are Differentially Affected in
HIV Infected Children. Keystone Symposium on HIV Pathogenesis. Keystone,
Colorado Mar 28 - Apr 3, 2001
7. Vecino WH, Morin P, Jacobs WR, Fennelly GJ. Highly attenuated Shigella flexneri
is superior to attenuated Salmonella typhimurium for mucosal DNA vaccination
against HIV. AIDS VACCINE 2001 Conference. Phila., PA Sept. 5-8 2001.
8. Vecino WH, Quanquin N, Garcia-Sastre A, Palese P, Jacobs WR, Jr. Fennelly GJ.
Mucosal DNA vaccination with highly attenuated Shigella flexneri protects against a
lethal influenza challenge. Ninth National Symposium on Basic Aspects of Vaccines.
Bethesda, MD Apr 30-May 2 2003.
9. Legrand FA, Abadi, A, Jordan KA, Fennelly GJ, Wiznia A, Nixon DF, Rosenberg
MG. Augmented HIV-Specific Immune Responses in Perinatally Infected Pediatric
Patients Undergoing Protease Inhibitor Partial Treatment Interruption. The 12th
International Congress of Immunology. Montreal July 18-23, 2004.
10. Vecino WH, Agha R, Sabally W, Jacobs WR, Jr and Fennelly GJ. Novel Bacterial
DNA Vaccination against Cervical Carcinoma. Cancer Research Institute
International Cancer Immunotherapy Symposia Series; Cancer Vaccines 2004: The
Next Decade. New York, NY October 4-6, 2004.
Page 10 of 14
11. Gonzalez, JM, Einstein, MH, Fennelly, GJ, Tesfa, L, Burk, RD, Neefe, J, Streicher,
H, and Kadish, AS. HspE7 immuno-therapy results in regression of biopsy-proven
CIN III lesions and enhanced in vitro T cell responses to HPV 16 E7 peptides. HPV
Immunotherapy, Vancouver, May 2005.
12. Ballan W, Vu B-A, Long B, Loo C, Michaelsson J, Wiznia A, Abadi J, Fennelly G,
Rosenberg M, Nixon DF. Increased expression of activating receptors on NK cells
in viremic HIV-1 infected children. Keystone 2006.
13. Vu B-A, Ballan W, , Loo C Long B, Michaelsson J Wiznia A, Abadi J, Fennelly G,
Rosenberg M, Nixon DF. Increased Natural Killer Cell Function in Viremic HIV
Infected Children. Keystone 2006.
14. Ranganathan U, Larsen M, Kim J, Cayabyab M, Jacobs WR, Jr, Fennelly G.
Neonatal recombinant attenuated M. tuberculosis priming against HIV-1. Prevention
of HIV/AIDS (X3), Keystone Conference, March 22 -March 27, 2009.
15. Jensen KL, Ranganathan U, Van Rompay K, Abbott Z, Larsen M, Fennelly G, Abel
K. A Novel, Attenuated Recombinant Mycobacterium Tuberculosis HIV Vaccine
Vector is Safe and Immunogenic in Infant Rhesus Macaques. ABSTRACT #35 27th
Annual Symposium on Nonhuman Primate Models for AIDS, Harvard University,
Cambridge, MA, Oct 27-31, 2009
16. Cayabyab MJ, Fennelly GJ, Kobayashi K, Haynes BF, Jacobs, WR Jr., Letvin NL
and Campos-Neto A. Antigen-specific memory CD8 T cells following recombinant
mycobacteria BCG and M. smegmatis vaccination: Impact of 19-kDa signal
sequence and toll-like receptors. Fourth Annual New England TB Symposium: TB
and HIV Co-infection, Broad Institute, Cambridge, MA, July 16, 2010.
17. Ranganathan UD, Sengupta M, Larsen MH, Porcelli SA, Jacobs WR, and Fennelly
GJ. Recombinant attenuated M. tuberculosis vaccine priming against SIV gag.
Fourth Annual New England TB Symposium: TB and HIV Co-infection, Broad
Institute, Cambridge, MA, July 16, 2010.
18. Jensen KL, Ranganathan U, Van Rompay K, Abbott Z, Larsen M, Fennelly G, Abel
K. A Novel Combination Vaccine for HIV-1 and Tuberculosis is Safe and
Immunogenic in Infant Rhesus Macaques. Keystone Immunology of Vaccination,
Seattle, WA, October 28-30, 2010. J Immunol. 2011, 186, 53.25 (access at:
http://jimmunol.org/cgi/content/meeting_abstract/186/1_MeetingAbstracts/53.25)
19. Jensen K, Ranganathan UD, Kozlowski P Van Rompay K, Canfield D, Ravindran R,
Khan I, Luciw P, Fennelly G, Larsen M, Abel K. Recombinant Attenuated
Mycobacterium Tuberculosis-SIV Combination Vaccine Is Safe and Immunogenic
in Immunocompromised, SIV-infected Infant Macaques, K Van Rompay, Abel
(Abstract OA01.04), AIDS Vaccine 2012. Boston, 9-12 September.
20. Ranganathan UD, Larsen M, Abel K, Jacobs WR Jr, Fennelly G. Recombinant
Attenuated M.Tuberculosis-SIVgag(rAMtb-gag) Vaccination Primes for SIVSpecific CD8 T Cell Response That Are Boosted by Ad5-SIVgag in Mice. (Abstract
P11.21), AIDS Vaccine 2012. Boston, 9-12 September.
21. Jensen K, Wilson R, Ranganathan U, Van Rompay K, Jacobs, W, Fennelly G,
Larsen M, Kozlowski P, Abel P. Vaccine-induced salivary IgA reduces SIV viremia
in neonatal rhesus macaques. (Abstract P4501) Immunology 2013 Meeting. Journal
Immunol., 2013, 190, 179.13
22. Jensen K, Wilson R, Piatak M, Lifson J, Ranganathan UD, Jacobs W Jr, Fennelly G,
Larsen M, Van Rompay K, Kozlowski P, Abel K. Vaccine-induced Intestinal and
Salivary IgA Correlates with Reduced Viremia in Orally-challenged Neonatal
Macaques. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A242-3.
23. Jensen K, dela Pena-Ponce1 MG, Piatak M, Jacobs WR Jr, Fennelly G, L Carissa,
Mollan KR, Hudgens MG, Amedee A, Estes J, Lifson JD, Van Rompay KK, Larsen
M, and De Paris K. The potential of attenuated Mycobacterium tuberculosis or BCG
vaccines to enhance oral SIV acquisition in infant macaques. Late Breaker Plenary
Session Abstract WEAA0106LB. 8th IAS Conference on Pathogenesis, Treatment &
Prevention, Vancouver, Canada 19-22 July, 2015
Page 11 of 14
PRESENTIONS:
A. Scientific (Basic Science):
 World Health Organization/UNDP Program of Vaccine Development Meeting on
Pathogenic Aspects of Measles Virus Infection. “Approaches to new measles virus
vaccines.” April 20-21, 1993, Montreux, Switzerland.

NIH Workshop on Measles Virus Pathogenesis and Vaccine Development.
“Recombinant BCG protects infant rhesus monkeys against measles.” September 27-28,
1996 Bethesda.

International AIDS Vaccine Initiative Workshop on Bacterial Vectors for developing
HIV. “Shigella and Salmonella to deliver HIV DNA vaccines.” September 19, 1999 New
York.

Visiting Scientist Seminar “Novel Mucosal Vaccines against Measles Virus and HIV.”
January 15, 2001. Instituto Butantan, Sao Paolo, Brazil.

Highly attenuated Shigella flexneri is superior to attenuated Salmonella typhimurium for
mucosal HIV DNA vaccination. AIDS Vaccine 2001. Phila., PA Sept. 5-8 2001

University of California at Davis, California National Primate Center. “Novel
Recombinant Bacterial Vaccines against Viral Pathogens”, Seminar Series. February 13,
2004

Bronx Lebanon Hospital. “New Generation Vaccines for the Developing World.”
Department of Medicine Research Seminar September 23, 1997 Bronx, NY.

SUNY-Downstate Medical Center. “Attenuated Bacteria as Vaccine Vectors”. HIV
Center/Infectious Diseases Seminar Series. Brooklyn, NY, June 5, 2003

University of Wisconsin, “Novel Recombinant Bacterial Vaccines Against Viral
Pathogens”, Pathology Seminar Series September 5, 2004

Annual Chilean Immunology Society Meeting “New uses for BCG and other furtherattenuated mycobacteria: Progress towards a combined TB/HIV vaccine”. La Serena,
Chile, October 4, 2006

NIAID, “Neonatal Immunopathology of Tuberculosis”, Many Hosts of Mycobacteria
Conference, NIAID, Gettysburg, PA, September 15 and 16, 2008

Rutgers New Jersey Medical School, “Development of a Combination Pediatric HIV-TB
Vaccine: balancing safety and risk”, Department of Microbiology and Molecular
Genetics Seminar, Newark, NJ October 29, 2013
B. Professional (Clinical):
 New York University Pediatric Nurse Practitioner Updates in Management Seminar
Series, “Use and Abuse of Antibiotics in the Treatment of Common Pediatric Infections.”
December 11, 1996 New York, NY.

Harvard School of Public Health. “Partial Treatment Interruption of HAART in Pediatric
Patients” August 19, 2005.

Pediatricians for Central America’s Children Seminar. “Prevention of mother-to-child
transmission (PMTCT) of HIV and Pediatric Highly Active Anti-Retroviral Treatment
(HAART): Lessons from the Bronx.” Winthrop Hospital, January 31, 2006.
Page 12 of 14

Vietnam-CDC-Harvard AIDS Partnership Visiting Professor August 1-30, 2006, Ho Chi
Minh City, Vietnam
 City-Wide HIV Rounds: “Case presentations: Management of ARV failure;
Second-line and Salvage ART in children”
 City-Wide HIV Rounds “Pediatric HIV: Prevention of Women to Child
 Transmission, Management of Pediatric Antiretroviral Failure and Toxicities”
 Tuberculosis Hospital: “Pediatric HIV and TB co-infection”

Manhattan Youth, Recreation and Resources and the American Red Cross.
Panelist: “How does the World Trade Center Attack Affect the Children of the
Neighborhood Five Years Later?” PS 89, NY, NY, September 7, 2006

Bronx-Wide Child Protection Seminar, HSV in suspected child abuse. North Bronx
Hospital Network, September 20, 2006.

Women’s Health: A Global Perspective in Honor of Allan Rosenfield, MD.
“Tuberculosis: Current Global Perspectives”. 25th Annual Einstein Fall Symposium
Saturday, New York November 11, 2006

Awassa Health Sciences University/Albert Einstein College of Medicine Joint Seminar
on Malaria, HIV and Tuberculosis: Awassa, Ethiopia, December 6-8, 2006.
 “Overview of Child Health in Ethiopia”
 “Prevention of Women to Child Transmission of HIV”
 “Management of Pediatric HIV Infection”

Tropical Disease Hospital, “Management of Opportunistic and Other Co-Infections in
Children with HIV Infection in Vietnam” HIV Grand Rounds, Ho Chi Minh City,
Vietnam. January 30, 2008.

Asian Pacific American Medical Student Association Conference. HAART against
Pediatric AIDS in Vietnam: Transferring Skills from New York to Hanoi. New York, NY.
April 5, 2008

University of Hawaii Postgraduate Medical Education Program. Okinawa Chubu
Hospital, Visiting Lecturer, Okinawa, Japan August 4-9, 2008.
 “Pediatric HIV/AIDS”
 “Pediatric Tuberculosis”
 “Confronting Pediatric AIDS in Viet Nam”
 “Antibiotic Updates”
 “Barriers to Vaccination against New and Emerging Infectious Threats”

Global Medic Force (formerly ICEHA). “Prevention, Care and Treatment of Pediatric
HIV Infection in Resource-Limited Settings”. Global Medic Force Volunteers Training
Workshop, New York, NY. September 27 th, 2008.

Newark Beth Israel, Children’s Hospital of New Jersey Grand Rounds. “Pediatric
Tuberculosis: Challenges for diagnosis, treatment and prevention of a persistent global
threat”, Newark, NJ. March 12, 2014.

NJMS Alumni Day Stuart Stevenson Memorial Lecture. “”Pediatric Multi-Drug Resistant
Bacterial Infections: Can We Treat Effectively?” Newark, NJ. May 2, 2014

Annual Pediatric Update. “Pediatric Hospital Acquired Infections: Can We Treat
Effectively?” Hilton Head, NC. May 21, 2014
Page 13 of 14

Sanzari Children’s Hospital Grand Rounds. “Pediatric Tuberculosis: Challenges for
diagnosis, treatment and prevention of a persistent global threat”, Hackensack, NJ. May
21, 2014

Rutgers New Jersey Medical School Pediatrics Grand Rounds discussant, “Fever in the
Returning Pediatric Traveler”, Newark, NJ, December 19. 2014

Rutgers New Jersey Medical School, Summer Medical and Dental Education Program
Lecture. HIV: “From Ignorance to Intelligence: a 30-year perspective of a pediatric &
adolescent infectious diseases physician”, Newark, NJ, July 19th 2015.

Rutgers New Jersey Medical School Pediatrics Grand Rounds discussant,
o “Pediatric Tuberculosis”, Newark, NJ March 20, 2015
o “Exserohilum paranasal sinus fungal ball in an immunocompetent Child”, Newark,
NJ, October 23, 2015

University of Iowa Pediatric Grand Rounds and Medical Scientist Training Program
“Confronting Pediatric TB and HIV in Vietnam and Beyond”, Iowa City, Iowa,
September 25, 2015

University of Dodoma Health Sciences-Rutgers Global Advancement and International
Affairs Inaugural Exchange Lectures: “Eradicating Pediatric HIV in Tanzania”;
“Pediatric Tuberculosis: Challenges for diagnosis, treatment and prevention of a
persistent global threat” and “Vaccination Targeting Neonatal Morbidity and Mortality”,
Dodoma, Tanzania January 6th through 16th, 2016
Page 14 of 14